Abstract
Introduction
Bacterial keratitis is considered a leading cause of monocular blindness in the developing world [1] . Staphylococcus is a common Gram-positive bacterium causing keratitis that tends to present with a focal and well-defined white or yellow-white infiltrate. During the infection, corneal inflammation can lead to neovascularization and scarring, while internal ocular inflammation can cause synechia formation, elevated intraocular pressure and cataract [1, 2] . Several staphylococcal strains have been reported resistant to topical quinolone therapy [3, 4] .
We report an unusual case of quinolone-resistant multifocal staphylococcal keratitis without a history of previous ocular pathology, which caused chronic intraocular pressure elevation despite successful keratitis treatment and complete resolution of external and internal ocular inflammation.
Case Presentation
A 67-year-old woman presented in the emergency section of our department with gradual onset of redness, tearing, photophobia and a 4-day history of blurred vision in her right eye. There was no history of contact lens wear, previous ocular disease, trauma or surgery. Examination of the right eye revealed visual acuity of counting fingers, intense conjunctival injection, mild corneal edema and three corneal ulcers of different extension (1-5 mm in diameter). A moderate aqueous flare was noted in the anterior chamber without presence of hypopyon or pupillary synechiae ( fig. 1 ). Intraocular pressure and fundus were normal, and there were no pathological findings in her left eye.
Corneal scrapings and conjunctival samples were obtained from the right eye and sent to the laboratory for culture. The patient was hospitalized and received empirical treatment with fortified vancomycin + tobramycin (Voncon, Lilly + Tobrex, Alcon) eye drops every 30 min the first day, every hour the second day and afterwards every 2 h. Topical cyclopentolate (Cyclogyl, Alcon) 3 times daily was also administered.
The cultures demonstrated the presence of two strains of coagulase-negative Staphylococcus epidermidis, one resistant to ciprofloxacin and both sensitive to vancomycin.
One week after treatment implementation, the patient reported partial relief from her initial symptoms. A considerable reduction of the extension of corneal ulcers was noted, though aqueous flare and intraocular pressure increased (32 mm Hg) and corneal neovascularization appeared at the limbus adjacent to the corneal ulcers. Treatment was modified to topical vancomycin, dexamethasone (Maxidex, Alcon) and cyclopentolate initially 3 times daily, with a progressive tapering scheme during the following 3 weeks. Topical brinzolamide (Azopt, Alcon) twice daily was also administered. The patient was discharged from hospital and scheduled for examination twice a week.
After the 3-week-period, the corneal ulcers were completely healed; there was no conjunctival injection, no visible aqueous flare but only a mild scarring at the superior limbus ( fig. 2 ). Corrected visual acuity was 0.8 and intraocular pressure was normal. Treatment was discontinued and follow-up was arranged twice monthly. Two months later, a persistent ocular hypertension (26-28 mm Hg) of unknown etiology and without any external or internal ocular inflammation was noted in the right eye at three consecutive visits. A Goldmann contact lens was used to perform a 360° gonioscopy that did not reveal any pathological findings. Intraocular pressure was normal in the left eye and corneal pachymetry was normal in both eyes. Topical brinzolamide was restarted and follow-up was continued monthly. For the next 6 months, intraocular pressure in the right eye fluctuated within normal limits and no inflammatory recurrence was observed. The patient remained under topical antiglaucoma therapy as described above.
in the setting of hydrophilic contact lens wear or after laser in situ keratomileusis. Multiple foci of abscesses resemble fungal satellite lesions [1, 5] .
In the present case, none of the above stated predisposing factors for multifocal epithelial infiltration existed. Furthermore, we did not detect any predisposing factors for chronic intraocular pressure elevation, such as history of glaucoma or ocular hypertension, trauma, relapsing inflammation and anterior or posterior synechiae.
The existence of aqueous flare in the anterior chamber could explain the temporary intraocular pressure rise diagnosed in the second week, though after total cessation of the inflammatory activity the intraocular pressure returned to normal values as expected. Steroid-induced ocular hypertension does not seem to be relevant since steroid treatment was of limited duration, low dosed and gradually discontinued. A possible explanation for the late and persistent intraocular pressure elevation may be a permanent damage of the trabecular meshwork caused by staphylococcal toxins. Despite normal appearance of the iridocorneal angle on gonioscopy, invisible microscopic changes could not be excluded.
The resistance of one S. epidermidis strain to ciprofloxacin is in accordance with previous reports and indicates that microbial culture is necessary in cases of extensive bacterial corneal ulcers [3, 4] . Furthermore, it also shows that an initial empirical treatment with a combination of fortified topical antibiotics may be superior to topical quinolone monotherapy in these cases. However, further evidence is required to support the above hypothesis since there are studies showing equivalence of fluoroquinolone monotherapy to fortified medications in microbial keratitis [6, 7] . Unfortunately, it was not possible for our laboratory to test the sensitivity of the ciprofloxacin-resistant strain to newer-generation quinolones, which could have had better activity against these Gram-positive organisms.
In conclusion, the present case demonstrates that in patients with multifocal keratitis, differential diagnosis between fungal and bacterial infection is critical for successful treatment. Besides treatment, patient follow-up and intraocular pressure monitoring may be needed, even after complete infection healing and resolution of inflammatory signs.
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